Lavipharm Overview

  • Founded
  • 1911
Founded
  • Status
  • Public
  • Stock Symbol
  • LAVI
Stock Symbol
  • Share Price
  • $0.56
  • (As of Friday Closing)

Lavipharm General Information

Description

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes innovative, safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
ATH
Primary Office
  • Agias Marinas Street
  • PO Box 59
  • Paiania, 190 02
  • Greece
+30 21 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lavipharm Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.56 $0.56 $0.23 - $0.61 $28.4M 51.1M 7.1K
Public Fundamental Data provided by Morningstar, Inc. disclaimer